Skip to content

Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor

Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05665309
Acronym
ILIAD
Enrollment
60
Registered
2022-12-27
Start date
2023-09-30
Completion date
2025-12-31
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm

Brief summary

This is a preliminary randomised controlled trial comparing the use of pre-operative 3D models to select an intrasaccular flow disruptor for endovascular aneurysm cure.

Detailed description

Patients will be randomised 3:1 either in the intervention or control group. Intervention consists of using the pre-operative Digital Subtraction Angiography (DSA) to create a 3D plastic model. This model is used to test different sizes of device. At the end of this pre-operative test a single device is recommended for the real procedure. The control group will use the current method for size selection (measurement of mean width and minimum height) on DSA.

Interventions

PROCEDURE3D anatomical model of aneurysm

Surgery prepared with 3D anatomical model of aneurysm

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Intracranial aneurysm, suitable for a treatment by Woven Endobridge (WEB) device after multidisciplinary team decision * Consent form signed * The patient benefits from health insurance

Exclusion criteria

* Legal incapacity * Women at risk of pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients with successful procedureDay 0Proportion of patients for which flow disruption succeeded at first intent, without any change of size required for WEB disruptor

Contacts

Primary ContactGuillaume CHARBONNIER, MD
g1charbonnier@chu-besancon.fr+33381668502

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026